If you have type 2 diabetes or high blood pressure, your risk of a heart attack or stroke is 2–4 times higher than the average person — and the earliest warning isn't in your heart, it's in your urine.
Heart disease and kidney disease share the same enemy — damage to tiny blood vessels caused by high sugar and high BP. Because the kidney filters are the most delicate vessels in the body, they show damage first. That damage shows up as albumin in urine — the body's earliest, loudest SOS for cardiovascular risk.
High sugar and high BP slowly injure small blood vessels in the heart, kidneys and brain — long before any symptom or blood-test abnormality.
The damaged kidney filters start letting albumin slip into urine. A uACR > 30 mg/g is a flashing red light: cardiovascular damage is in progress.
Without action, the same damage hits the heart — heart attack, stroke, heart failure. By that point, the SOS sign in your urine had been on for years.
If any of these apply, your cardiovascular risk is sharply elevated — and a uACR test will tell you whether the damage has already started.
Diabetes is the single biggest driver of both kidney disease and cardiovascular events. The two march together.
Uncontrolled BP damages the heart and kidney filters at the same time — and each makes the other worse.
Even a slightly elevated uACR multiplies your risk of heart attack and stroke, independent of cholesterol or BP.
If you've had any cardiovascular event, the same vascular damage is silently affecting your kidneys.
Heart disease, stroke, or kidney disease in close family members raises your baseline risk significantly.
Both accelerate damage to the small blood vessels of the heart and kidneys at the same time.
The uACR (Urine Albumin-to-Creatinine Ratio) test is the single most cost-effective way to spot hidden cardiovascular damage early. Done at home, in under a minute, on your phone. If it's normal — peace of mind. If it's elevated — you have time to act, with your doctor, before a heart event.

A meta-analysis of 1.2 million people (Lancet, 2010) showed that elevated uACR predicts heart attack and stroke even after adjusting for cholesterol, BP, smoking and diabetes.
KDIGO data shows that people with preserved kidney function (normal eGFR) but elevated uACR have up to 10× higher cardiovascular mortality than those with normal uACR.
Trials of SGLT2 inhibitors and ARBs show that lowering uACR translates directly into fewer heart attacks, fewer strokes and fewer heart failure hospitalisations.